843 related articles for article (PubMed ID: 26474322)
1. Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese.
Cestari T; Prati C; Menegon DB; Prado Oliveira ZN; Machado MC; Dumet J; Nakano J; Murrell DF
Int J Dermatol; 2016 Feb; 55(2):e94-9. PubMed ID: 26474322
[TBL] [Abstract][Full Text] [Related]
2. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
[TBL] [Abstract][Full Text] [Related]
3. Transcultural Validation of a Spanish Version of the Quality of Life in Epidermolysis Bullosa Questionnaire.
Villar Hernández AR; Molero Alonso F; Aguado Marín ÁJ; Posada de la Paz M
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742308
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in epidermolysis bullosa.
Horn HM; Tidman MJ
Clin Exp Dermatol; 2002 Nov; 27(8):707-10. PubMed ID: 12472552
[TBL] [Abstract][Full Text] [Related]
5. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).
Loh CC; Kim J; Su JC; Daniel BS; Venugopal SS; Rhodes LM; Intong LR; Law MG; Murrell DF
J Am Acad Dermatol; 2014 Jan; 70(1):89-97.e1-13. PubMed ID: 24355263
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population.
Yuen WY; Frew JW; Veerman K; van den Heuvel ER; Murrell DF; Jonkman MF
Acta Derm Venereol; 2014 Jul; 94(4):442-7. PubMed ID: 24337132
[TBL] [Abstract][Full Text] [Related]
8. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.
Frew JW; Martin LK; Nijsten T; Murrell DF
Br J Dermatol; 2009 Dec; 161(6):1323-30. PubMed ID: 19681875
[TBL] [Abstract][Full Text] [Related]
9. Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire.
Salamon G; Strobl S; Field-Werners U; Welponer T; Murrell DF; Diem A
J Health Psychol; 2024 Feb; ():13591053231221369. PubMed ID: 38369713
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the cross-cultural adaptation and validation process: linguistic and psychometric testing of the Brazilian-Portuguese version of a self-report measure for dry eye.
Santo RM; Ribeiro-Ferreira F; Alves MR; Epstein J; Novaes P
J Clin Epidemiol; 2015 Apr; 68(4):370-8. PubMed ID: 25619561
[TBL] [Abstract][Full Text] [Related]
11. "Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires.
Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D
Ital J Pediatr; 2024 Apr; 50(1):76. PubMed ID: 38637879
[TBL] [Abstract][Full Text] [Related]
12. Translation, cultural adaptation and validation for Brazilian Portuguese of the Cardiff Acne Disability Index instrument.
Grando LR; Horn R; Cunha VT; Cestari TF
An Bras Dermatol; 2016 Apr; 91(2):180-6. PubMed ID: 27192517
[TBL] [Abstract][Full Text] [Related]
13. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status and family size.
Fine JD; Johnson LB; Weiner M; Suchindran C
Br J Dermatol; 2005 May; 152(5):1009-14. PubMed ID: 15888161
[TBL] [Abstract][Full Text] [Related]
14. A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB).
Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF
JAAD Int; 2021 Mar; 2():134-152. PubMed ID: 34409361
[TBL] [Abstract][Full Text] [Related]
15. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa.
Fine JD; Johnson LB; Weiner M; Suchindran C
Clin Exp Dermatol; 2004 Mar; 29(2):122-7. PubMed ID: 14987264
[TBL] [Abstract][Full Text] [Related]
16. Cross-cultural adaptation of the Child Perceptions Questionnaire 11-14 (CPQ11-14) for the Brazilian Portuguese language.
Goursand D; Paiva SM; Zarzar PM; Ramos-Jorge ML; Cornacchia GM; Pordeus IA; Allison PJ
Health Qual Life Outcomes; 2008 Jan; 6():2. PubMed ID: 18194552
[TBL] [Abstract][Full Text] [Related]
17. Translation into Portuguese, cross-cultural adaptation and validation of "The European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-Bone Metastases-22".
Miki-Rosário N; Garcia Filho RJ; Garcia JG; Dini GM; Bottomley A; Chow E; Sabino Neto M
Ann Palliat Med; 2016 Jul; 5(3):190-5. PubMed ID: 27334351
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the prevalence of osteoporosis and osteopenia in patients with epidermolysis bullosa: A cross-sectional study.
Kang M; Chen JSC; Radjenovic M; Yang A; Feng GHY; Murrell DF
Exp Dermatol; 2021 Nov; 30(11):1675-1685. PubMed ID: 33347654
[TBL] [Abstract][Full Text] [Related]
20. The Birmingham Epidermolysis Bullosa Severity score: development and validation.
Moss C; Wong A; Davies P
Br J Dermatol; 2009 May; 160(5):1057-65. PubMed ID: 19434791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
